JINGXIN(002020.SZ)

Last Updated 00:00:00
longbridge loading

JINGXIN: Cumulative repurchase of 609 million yuan

Zhitong·
SZ
002020
+0.63%
Zhitong·
SZ
002020
+0.63%

JINGXIN has repurchased 5.49% of its shares, costing 609 million yuan

Zhitong·
SZ
002020
+0.63%
Zhitong·
SZ
002020
+0.63%

JINGXIN: Net profit in the first half of 2025 is 388 million yuan, a year-on-year decrease of 3.54%

Zhitong·
SZ
002020
+0.63%
Zhitong·
SZ
002020
+0.63%

JINGXIN: As of the announcement date, a total of 290 million yuan of the raised funds for temporarily supplementing working capital has been fully returned to the special account for raised funds, and the usage period has not exceeded 12 months

Zhitong·
SZ
002020
+0.63%
Zhitong·
SZ
002020
+0.63%

The traditional Chinese medicine concept continues to strengthen, with Layn hitting the daily limit, and companies such as Zhongsheng Pharmaceutical, Kanion Pharmaceutical, JINGXIN, Zhendong Pharmacy, CONBA, and Chase Sun also rising

Zhitong·
SH
600572
-1.64%
SZ
300026
-1.50%
SZ
002166
+1.13%
Zhitong·
SH
600572
-1.64%
SZ
300026
-1.50%
SZ
002166
+1.13%

JINGXIN: Currently, it has not yet involved in the field of brain-machine interface technology

Zhitong·
SZ
002020
+0.63%
Zhitong·
SZ
002020
+0.63%

Innovative drug concept rebounds after hitting the bottom, Junshi Biosciences and others rise over 5%

Zhitong·
SZ
002020
+0.63%
SZ
300436
+1.24%
SH
688180
+2.26%
Zhitong·
SZ
002020
+0.63%
SZ
300436
+1.24%
SH
688180
+2.26%

JINGXIN Pharmaceutical signed a patent licensing agreement related to the hydrochloride of carbidopa formulations and raw materials

Zhitong·
SZ
002020
+0.63%
Zhitong·
SZ
002020
+0.63%

Innovative drug concept stocks saw a partial rebound, with Hanyu Pharmaceutical surging over 10% in the afternoon, Hicin Pharmaceutical, Sun-Novo, and Guangshengtang also rising over 10%. Fuyuan Pharmaceutical and WEDGE CORPORATION hit the daily limit, while Longshen Rongfa, JINGXIN, CSBIO, and Staidson BioPharm followed suit

Zhitong·
SZ
300584
-1.40%
SH
688621
-0.46%
SZ
000534
-4.00%
Zhitong·
SZ
300584
-1.40%
SH
688621
-0.46%
SZ
000534
-4.00%

JINGXIN: The proportion of shares repurchased by the company has reached 5%

Zhitong·
SZ
002020
+0.63%
Zhitong·
SZ
002020
+0.63%
© 2026 Longbridge｜Disclaimer